N-[(3-bromo-1,2-oxazol-5-yl)methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(3-bromo-1,2-oxazol-5-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(1R)-1-[1-(4-methylphenyl)sulfonyl-4-methylsulfonylpyrrol-2-yl]propyl]pyrazolo[5,4-c]pyridine-4-carboxamide

C101H80Br4F5N25O11S4 — CID 157363657

IUPACN-[(3-bromo-1,2-oxazol-5-yl)methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(3-bromo-1,2-oxazol-5-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(1R)-1-[1-(4-methylphenyl)sulfonyl-4-methylsulfonylpyrrol-2-yl]propyl]pyrazolo[5,4-c]pyridine-4-carboxamide
SMILESCC[C@@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1cc(S(C)(=O)=O)cn1S(=O)(=O)c1ccc(C)cc1.CC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1cc(Br)no1.CC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1nc(Br)cs1.C[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1nc(Br)cs1.O=C(NCc1cc(Br)no1)c1cncc2c1cnn2-c1ccc(F)cc1
InChIInChI=1S/C28H26FN5O5S2.C19H15BrFN5O2.C19H15BrFN5OS.C18H13BrFN5OS.C17H11BrFN5O2/c1-4-25(26-13-22(40(3,36)37)17-33(26)41(38,39)21-11-5-18(2)6-12-21)32-28(35)24-14-30-16-27-23(24)15-31-34(27)20-9-7-19(29)8-10-20;1-2-15(17-7-18(20)25-28-17)24-19(27)14-8-22-10-16-13(14)9-23-26(16)12-5-3-11(21)4-6-12;1-2-15(19-25-17(20)10-28-19)24-18(27)14-7-22-9-16-13(14)8-23-26(16)12-5-3-11(21)4-6-12;1-10(18-24-16(19)9-27-18)23-17(26)14-6-21-8-15-13(14)7-22-25(15)12-4-2-11(20)3-5-12;18-16-5-12(26-23-16)6-21-17(25)14-7-20-9-15-13(14)8-22-24(15)11-3-1-10(19)2-4-11/h5-17,25H,4H2,1-3H3,(H,32,35);2*3-10,15H,2H2,1H3,(H,24,27);2-10H,1H3,(H,23,26);1-5,7-9H,6H2,(H,21,25)/t25-;2*15-;10-;/m1000./s1
InChIKeyBIXSXVOHVBITSG-CJMPOLFHSA-N
MW2362.79 g/mol
LogP20.55
Rot. Bonds26

About N-[(3-bromo-1,2-oxazol-5-yl)methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(3-bromo-1,2-oxazol-5-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(1R)-1-[1-(4-methylphenyl)sulfonyl-4-methylsulfonylpyrrol-2-yl]propyl]pyrazolo[5,4-c]pyridine-4-carboxamide

N-[(3-bromo-1,2-oxazol-5-yl)methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(3-bromo-1,2-oxazol-5-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(1R)-1-[1-(4-methylphenyl)sulfonyl-4-methylsulfonylpyrrol-2-yl]propyl]pyrazolo[5,4-c]pyridine-4-carboxamide (PubChem CID 157363657) has the molecular formula C101H80Br4F5N25O11S4 and a molecular weight of 2362.79 g/mol. Its IUPAC name is N-[(3-bromo-1,2-oxazol-5-yl)methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(3-bromo-1,2-oxazol-5-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(1R)-1-[1-(4-methylphenyl)sulfonyl-4-methylsulfonylpyrrol-2-yl]propyl]pyrazolo[5,4-c]pyridine-4-carboxamide.

Molecular Properties

Compound NameN-[(3-bromo-1,2-oxazol-5-yl)methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(3-bromo-1,2-oxazol-5-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(1R)-1-[1-(4-methylphenyl)sulfonyl-4-methylsulfonylpyrrol-2-yl]propyl]pyrazolo[5,4-c]pyridine-4-carboxamide
PubChem CID157363657
Molecular FormulaC101H80Br4F5N25O11S4
Molecular Weight2362.79 g/mol
Exact Mass2357.20
IUPAC NameN-[(3-bromo-1,2-oxazol-5-yl)methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(3-bromo-1,2-oxazol-5-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(1R)-1-[1-(4-methylphenyl)sulfonyl-4-methylsulfonylpyrrol-2-yl]propyl]pyrazolo[5,4-c]pyridine-4-carboxamide
SMILESCC[C@@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1cc(S(C)(=O)=O)cn1S(=O)(=O)c1ccc(C)cc1.CC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1cc(Br)no1.CC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1nc(Br)cs1.C[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1nc(Br)cs1.O=C(NCc1cc(Br)no1)c1cncc2c1cnn2-c1ccc(F)cc1
InChIInChI=1S/C28H26FN5O5S2.C19H15BrFN5O2.C19H15BrFN5OS.C18H13BrFN5OS.C17H11BrFN5O2/c1-4-25(26-13-22(40(3,36)37)17-33(26)41(38,39)21-11-5-18(2)6-12-21)32-28(35)24-14-30-16-27-23(24)15-31-34(27)20-9-7-19(29)8-10-20;1-2-15(17-7-18(20)25-28-17)24-19(27)14-8-22-10-16-13(14)9-23-26(16)12-5-3-11(21)4-6-12;1-2-15(19-25-17(20)10-28-19)24-18(27)14-7-22-9-16-13(14)8-23-26(16)12-5-3-11(21)4-6-12;1-10(18-24-16(19)9-27-18)23-17(26)14-6-21-8-15-13(14)7-22-25(15)12-4-2-11(20)3-5-12;18-16-5-12(26-23-16)6-21-17(25)14-7-20-9-15-13(14)8-22-24(15)11-3-1-10(19)2-4-11/h5-17,25H,4H2,1-3H3,(H,32,35);2*3-10,15H,2H2,1H3,(H,24,27);2-10H,1H3,(H,23,26);1-5,7-9H,6H2,(H,21,25)/t25-;2*15-;10-;/m1000./s1
InChIKeyBIXSXVOHVBITSG-CJMPOLFHSA-N
XLogP20.55
TPSA450.10 Ų
H-Bond Donors5
H-Bond Acceptors33
Rotatable Bonds26
Heavy Atoms150
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002362.79
LogP ≤ 520.55
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1033

Analyze N-[(3-bromo-1,2-oxazol-5-yl)methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(3-bromo-1,2-oxazol-5-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(1R)-1-[1-(4-methylphenyl)sulfonyl-4-methylsulfonylpyrrol-2-yl]propyl]pyrazolo[5,4-c]pyridine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(3-bromo-1,2-oxazol-5-yl)methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(3-bromo-1,2-oxazol-5-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(1R)-1-[1-(4-methylphenyl)sulfonyl-4-methylsulfonylpyrrol-2-yl]propyl]pyrazolo[5,4-c]pyridine-4-carboxamide?
The IUPAC name of N-[(3-bromo-1,2-oxazol-5-yl)methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(3-bromo-1,2-oxazol-5-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(1R)-1-[1-(4-methylphenyl)sulfonyl-4-methylsulfonylpyrrol-2-yl]propyl]pyrazolo[5,4-c]pyridine-4-carboxamide (CID 157363657) is N-[(3-bromo-1,2-oxazol-5-yl)methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(3-bromo-1,2-oxazol-5-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(1R)-1-[1-(4-methylphenyl)sulfonyl-4-methylsulfonylpyrrol-2-yl]propyl]pyrazolo[5,4-c]pyridine-4-carboxamide.
What is the SMILES notation for N-[(3-bromo-1,2-oxazol-5-yl)methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(3-bromo-1,2-oxazol-5-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(1R)-1-[1-(4-methylphenyl)sulfonyl-4-methylsulfonylpyrrol-2-yl]propyl]pyrazolo[5,4-c]pyridine-4-carboxamide?
The canonical SMILES for N-[(3-bromo-1,2-oxazol-5-yl)methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(3-bromo-1,2-oxazol-5-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(1R)-1-[1-(4-methylphenyl)sulfonyl-4-methylsulfonylpyrrol-2-yl]propyl]pyrazolo[5,4-c]pyridine-4-carboxamide is CC[C@@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1cc(S(C)(=O)=O)cn1S(=O)(=O)c1ccc(C)cc1.CC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1cc(Br)no1.CC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1nc(Br)cs1.C[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1nc(Br)cs1.O=C(NCc1cc(Br)no1)c1cncc2c1cnn2-c1ccc(F)cc1.
What is the InChIKey of N-[(3-bromo-1,2-oxazol-5-yl)methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(3-bromo-1,2-oxazol-5-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(1R)-1-[1-(4-methylphenyl)sulfonyl-4-methylsulfonylpyrrol-2-yl]propyl]pyrazolo[5,4-c]pyridine-4-carboxamide?
The InChIKey is BIXSXVOHVBITSG-CJMPOLFHSA-N. The full InChI is InChI=1S/C28H26FN5O5S2.C19H15BrFN5O2.C19H15BrFN5OS.C18H13BrFN5OS.C17H11BrFN5O2/c1-4-25(26-13-22(40(3,36)37)17-33(26)41(38,39)21-11-5-18(2)6-12-21)32-28(35)24-14-30-16-27-23(24)15-31-34(27)20-9-7-19(29)8-10-20;1-2-15(17-7-18(20)25-28-17)24-19(27)14-8-22-10-16-13(14)9-23-26(16)12-5-3-11(21)4-6-12;1-2-15(19-25-17(20)10-28-19)24-18(27)14-7-22-9-16-13(14)8-23-26(16)12-5-3-11(21)4-6-12;1-10(18-24-16(19)9-27-18)23-17(26)14-6-21-8-15-13(14)7-22-25(15)12-4-2-11(20)3-5-12;18-16-5-12(26-23-16)6-21-17(25)14-7-20-9-15-13(14)8-22-24(15)11-3-1-10(19)2-4-11/h5-17,25H,4H2,1-3H3,(H,32,35);2*3-10,15H,2H2,1H3,(H,24,27);2-10H,1H3,(H,23,26);1-5,7-9H,6H2,(H,21,25)/t25-;2*15-;10-;/m1000./s1.
What are the key properties of N-[(3-bromo-1,2-oxazol-5-yl)methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(3-bromo-1,2-oxazol-5-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(1R)-1-[1-(4-methylphenyl)sulfonyl-4-methylsulfonylpyrrol-2-yl]propyl]pyrazolo[5,4-c]pyridine-4-carboxamide?
N-[(3-bromo-1,2-oxazol-5-yl)methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(3-bromo-1,2-oxazol-5-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(1R)-1-[1-(4-methylphenyl)sulfonyl-4-methylsulfonylpyrrol-2-yl]propyl]pyrazolo[5,4-c]pyridine-4-carboxamide has a molecular weight of 2362.79 g/mol, XLogP of 20.55, 26 rotatable bonds, 5 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3-bromo-1,2-oxazol-5-yl)methyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(3-bromo-1,2-oxazol-5-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)ethyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;N-[(1S)-1-(4-bromo-1,3-thiazol-2-yl)propyl]-1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carboxamide;1-(4-fluorophenyl)-N-[(1R)-1-[1-(4-methylphenyl)sulfonyl-4-methylsulfonylpyrrol-2-yl]propyl]pyrazolo[5,4-c]pyridine-4-carboxamide is sourced from PubChem (CID 157363657), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).